Ever been stuck on the road far from home with a breakdown? Not fun. So imagine getting an email or text warning weeks or months before a starter quits, a battery dies or a fuel pump fails. Some of ...
Alerted by prognostics to a problem with a component or part, a fleet may not choose to take a risk on it performing another 20,000 miles before regularly scheduled truck maintenance. “Because it’s 50 ...
"Lee is a highly accomplished leader with commercial expertise in fostering innovation, supporting continuous optimization and driving sales and offers a history of strong performance within the ...
The average one-year price target for Sera Prognostics (NasdaqGM:SERA) has been revised to $5.10 / share. This is an increase ...
Meaningful progress on payer initiatives, including an inaugural pilot in Nevada actively enrolling Medicaid patients, while engaging with multiple payers across thirteen states, collectively ...
DALLAS. Prognostics – being able to predict a component or part failure in advance – will be the true growth area in telematics in the coming decade, at least in North America and Europe, a leading ...
Sera Prognostics is a promising company with a mission to improve pregnancy outcomes through its blood test product, PreTRM, which identifies biomarkers linked to premature birth. Premature birth is a ...
The company reiterated plans to publish the PRIME study in a peer-reviewed journal by year-end and to host an investor and analyst event immediately following acceptance. Management expects a "steady ...
SERA is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of SERA shares has decreased $0.02 since the market last closed. This is a 0.56% ...
Sera Prognostics, which develops diagnostic tests for pregnancy complications, raised $75 million by offering 4.7 million shares at $16, within the range of $15 to $17. Sera Prognostics uses its ...
Hosted on MSN
Sera Prognostics (SERA) Upgraded to Buy: Here's Why
Sera Prognostics, Inc. (SERA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results